Indian healthcare is entering a new growth cycle, with hospitals and CDMO players expected to deliver strong 20% EBITDA CAGR, while large generic pharma companies may face earnings pressure by FY27, says JM Financial’s Amey Chalke. Despite tariff concerns, In…
The Nasdaq has had a huge rally, but it could just be getting started. Read Full Article →
Preview Noble (NE) Q1 earnings April 26: EPS $0.20, revenue $742.19M, with past beats. Read Full Article →
Personal finance advice is a far cry from what it was in your grandparents’ day. Read Full Article →
Ken Martin celebrated Democrats' momentum heading into the midterms, despite the DNC's worrying fundraising numbers. Read Full Article →
